Results 141 to 150 of about 2,225,996 (214)

Artificial Intelligence for Medicines Information: Scoping Review of Clinical Applications and Digital Health Inequalities.

J Med Internet Res
Al-Arkee S, Falade J, Paudyal V.
europepmc   +1 more source

Cross-sectional study to assess filarial infection among the never treated individuals in selected districts in India: a study protocol. [PDF]

BMJ Open
Dinesh RJ, Srividya A, Jabir M, Kishanthini M, Dogra V, Tripathi B, Sharma R, Jain T, Rahi M.   +8 more
europepmc   +1 more source

Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert Panel. [PDF]

Clin Drug Investig
Karsten Dafonte K, Lutz P, Jansen C, Busse M, Dietrich P, Farker K, Lipp HP, Nattermann J, Sauerbruch T, Schmiedl S, Strobach D, Trebicka J, Zocholl D, Hartmann G, Jaehde U, Coenen M.   +15 more
europepmc   +1 more source

How to evaluate rare disease policy effectiveness based on policy modeling consistency (PMC) index model: A quantitative assessment of policy implementation in China. [PDF]

Intractable Rare Dis Res
Zhao Y, Zhang X, He D, Li Y, Dong R, Gu Y, Xie J.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

European Drug information Centers

Journal of Human Lactation, 1996
Drug information is a clinical specialty throughout the United States and Europe. This professional support service not only addresses drug information requests, but also provides pharmacy (drug) and therapeutics support, newsletter publication, feefor-service consultation, education, drug policy development, and research.
J E, Markind, J M, Stachnik
openaire   +2 more sources

National audit of drug information centers

American Journal of Health-System Pharmacy, 1985
A comprehensive audit of drug information centers (DICs) was conducted to obtain information on sources of funding, staffing, information resources, computerization, workload, and scope of services and activities and to examine the role of DICs in education, patient care, and research. Responses were obtained from 98 of the 121 DICs surveyed. The scope
S R, Dombrowski, J A, Visconti
openaire   +2 more sources

Current status of drug information centers

American Journal of Health-System Pharmacy, 1992
The current status of drug information centers in the United States and trends that have developed over the past two decades were studied. In February 1990, questionnaires were sent to 218 pharmacist-operated drug information centers nationwide. The centers were identified through previously published directories and the ASHP electronic bulletin board ...
S L, Beaird, R M, Coley, K A, Crea
openaire   +2 more sources

Role of FDA’s drug information centers

American Journal of Health-System Pharmacy, 2008
Q: What unique dimension does the federal government add to the role of a drug information center (DIC)? A: The first formalized DIC, established in 1962 at the University of Kentucky, served as a prototype for other institutions.[1][1] Since then, DICs have expanded outside academic settings ...
Kavita C, Dada, Mary E, Kremzner, Sanjeev K, Bhanot, Renu, Lal   +3 more
openaire   +2 more sources